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ABSTRACT
Although DNA-recognition sequences are among
the most important characteristics of restriction
enzymes and their corresponding methylases,
determination of the recognition sequence of a
Type-I restriction enzyme is a complicated proce-
dure. To facilitate this process we have previously
developed plasmid R-M tests and the computer
program RM search. To specifically identify Type-I
isoschizomers, we engineered a pUC19 derivative
plasmid, pTypeI, which contains all of the 27 Type-I
recognition sequences in a 248-bp DNA fragment.
Furthermore, a series of 27 plasmids (designated
‘reference plasmids’), each containing a unique
Type-I recognition sequence, were also constructed
using pMECA, a derivative of pUC vectors. In this
study, we tried those vectors on 108 clinical E. coli
strains and found that 48 strains produced isoschi-
zomers of Type I enzymes. A detailed study of 26
strains using these ‘reference plasmids’ revealed
that they produce seven different isoschizomers of
the prototypes: EcoAI, EcoBI, EcoKI, Eco377I,
Eco646I, Eco777I and Eco826I. One strain EC1344
produces two Type I enzymes (EcoKI and Eco377I).
INTRODUCTION
Restriction enzymes and their corresponding methylases
(R-M enzymes) are produced by various bacterial species
and are traditionally classiﬁed into three diﬀerent types
(1). Recently, Roberts et al. (2) have proposed a new class
IV for restriction enzymes speciﬁc to methylated DNA.
Although close to 4000 restriction enzymes are already
known, current genome projects reveal the possible
existence of many additional R-M systems in diverse
bacterial species (3).
Identiﬁcation of the recognition sequences is relatively
simple for Type II enzymes, since either the crude extracts
or partially puriﬁed Type II enzymes cut DNA at
distinctive locations, resulting in ﬁxed lengths of frag-
ments. Subsequently, computer programs help to deter-
mine the possible cutting sites from the fragments (3,4).
This convenient method, however, cannot be used for
Type I enzymes. These enzymes do not produce any
distinctive DNA fragments in the crude extracts because
those enzymes cut DNA far from the recognition
sequences and at random positions. Thus, no simple
method to identify recognition sequences has yet been
developed for Type I or Type III enzymes. One alter-
native approach is to identify the binding site of the
companion methylase, which is shared by the restriction
endonuclease (5). However, characterizing the methyla-
tion site requires extensive enzyme puriﬁcation, isotope
labeling and the application of a computer program to
analyze the results. This protocol is not suitable for quick
screening of many bacterial strains.
As shown by the extensive list of the isoschizomers
of the Type II enzymes (273 prototypes and more than
3400 isoschizomers) (3), ﬁnding new prototype enzymes
has rapidly become more diﬃcult. It is possible that many
of the more than 1000 putative Type II enzymes found
through genome analysis are also isoschizomers. On the
other hand, only a handful of active Type I and Type III
enzymes (60 and 7, respectively) have been discovered so
far. Among the 60 Type I enzymes, the recognition
sequences of only half (32 enzymes) have been identiﬁed.
This includes 27 naturally occurring recognition sequences
and ﬁve artiﬁcially constructed recognition sequences.
From various bacterial genome projects about 1200 put-
ative Type I enzymes and about 300 putative Type III
*To whom correspondence should be addressed. Email: erowsell@llu.edu
I regret to inform our readers that Dr Junichi Ryu died before publication of this article.
 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.enzymes have been identiﬁed (3). Thus, there are many
more Type I and Type III restriction enzymes to be
characterized.
A simple and economical method to identify Type I and
Type III recognition sequences is needed. As described
elsewhere (6), we have applied the classical phage EOP
(Eﬃciency of Plating) assay to a chemical plasmid
transformation protocol and developed plasmid R-M
tests to detect the presence of restriction enzymes in
bacterial cells. With these tests, together with the
introduction of a new computer program, RM search
(7), we have developed a novel method to identify their
recognition sequences (6). This method was used to
identify several recognition sequences for Type I enzymes
in bacteria belonging to the Klebsiella and Salmonella
genera (8,9). It was also used to ﬁnd new restriction
enzymes in clinical E. coli strains (6). The application of
this method resulted in a doubling of the number of
known recognition sequences for the naturally occurring
Type I enzymes from 14 to 27 and two EcoBI
isoschizomers were found (3). Our data also showed that
this plasmid transformation method is useful for detecting
not only the activities of Type I enzymes but also those of
Type II and Type III enzymes (6). Nevertheless, because
of the complexity of the recognition sequences of the Type
III enzymes, the elucidation of their recognition sequences
using the RM search program has been so far limited to
Type I and Type II enzymes (7).
Although the total number of known Type I recognition
sequences is only 32 and the potential to ﬁnd many more
new recognition sequences is high at present, we still
expect to encounter many isoschizomers in the process of
screening for Type I enzymes. To quickly distinguish new
prototypes from isoschizomers, we have developed here a
modiﬁed pUC19 plasmid, pTypeI, which contains all
the presently known Type I recognition sequences. If a
test bacterial strain produces one of the known Type I
enzymes, they will restrict pTypeI on transformation and
as a result, produce fewer transformants than a control
plasmid without the recognition sequence. Each of the
isoschizomer sequences can be estimated using a plasmid
chart developed in this project and then can be conﬁrmed
by using the complete set of reference plasmids developed
here. We have performed a feasibility study on these
plasmids using E. coli strains readily available from our
hospital and show here the usefulness of the plasmids by
identifying 27 Type I isoschizomers.
MATERIALS AND METHODS
Bacterial strains
Bacteria producing known Type I restriction enzymes
(Table 1) were all from our lab collection. Approximately
700 clinical E. coli strains were obtained originally from
the clinical laboratory of Loma Linda University Medical
Center between 2000 and 2004. Some of them were
previously used to identify new Type I enzymes (6,10). In
this study, 108 ampicillin-sensitive E. coli strains, a subset
of those clinical samples, were used for the screening of
Type I isoschizomers. Some of the E. coli strains
containing Salmonella Type I restriction enzymes
(E. coli–Salmonella hybrid) (11) were also used in this
study.
pTypeI plasmid
The 248-bp insertion fragments of the pTypeI plasmid was
synthesized by Midland Certiﬁed Reagent Company
(Midlands, Texas) and inserted at the HincII site of
pUC19 (12) (Figure 1). This DNA fragment contains
27 naturally occurring Type I recognition sequences
overlapping each other. It consists of two sub-fragments;
fragments A (117bp) which contains the 17 recognition
sequences found so far in E. coli and fragment B (113bp)
which contains the remaining 10 Type I recognition
sequences found in other bacteria. When the prototype
recognition sequence contains degenerate bases, only one
base was selected, thus only one sequence is represented
for each prototype. In addition to the recognition
sequences, fragment B contains a portion of the MCS
(multiple cloning site) of pUC19 in such a way that the
entire section, which consists of a ‘Type I sequence
cassette’ (about 250bp, Figure 1), can be excised from the
pTypeI plasmid and transferred to any other vectors using
restriction enzymes such as EcoRI, KpnI and BamHI.
Thus, once subcloned into plasmids able to replicate in
other genera, this fragment can be used to characterize
Type I systems in a variety of non-enteric bacteria.
The EcoRV sites are located at both ends of the 248-bp
fragment. In addition, fragments A and B are ﬂanked by a
unique EcoRV site. This allows ligation of each fragment
to any blunt end cloning sites.
Reference plasmids
To conﬁrm the predicted pattern for each Type I
recognition sequence, a series of plasmids each containing
a single Type I recognition site have been constructed.
These plasmids were termed collectively as the reference
plasmids (9). An example of the reference plasmid with the
Table 1 Plasmid restriction tests using pTypeI for known R-M systems
Strains Type I
system
Restriction
EOT (STD)
Source or
reference
E. coli system
2739 EcoAI 4.410
2 (310
2) Lab stock
L4001 EcoBI 4.810
2 (710
2) Lab stock
1225 EcoKI 3.310
2 (510
2) Lab stock
EC377 Eco377I 1.110
1 (210
1) (6)
EC585 Eco585I 1.110
1 (110
1) (6)
EC646 Eco646I 4.910
2 (310
2) (6)
EC777 Eco777I 6.710
3 (110
2) (6)
EC394 Eco394I 2.710
3 (310
3) (10)
EC912 Eco912I 1.510
2 (210
2) (10)
Salmonella system
L4029 StySEAI 7.210
2 (610
2) (11)
L4039 StySGI 9.410
2 (110
1) (11)
EOT (Eﬃciency of Transformation) is number of transformants with
pTypeI/number of transformants with pMECA. Except for EcoKI, the
pMECA plasmid does not contain the relevant recognition sequences
for the test strains. In case of EcoKI, an EcoKI modiﬁed pMECA was
used as a control. Each value is the average of three experiments.
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reported previously about a half (13/27) of those reference
plasmids for Type I enzymes (6–10), only the remaining
reference plasmids were constructed here. These are
pCfrAI, pEcoAI, pEcoDI, pEcoXXI, pEcoEI, pEcoKI,
pEco124I, pEco124II, pEcoprrI, pNgoAV, pStyLTIII,
pSKI and pSPI, each containing the recognition sequence
for the Type I enzymes indicated in its name.
Oligonucleotide production and DNA sequencing were
carried out at the core facility in the Center for Molecular
Biology, Loma Linda University.
Plasmid R-M tests
Plasmid restriction and modiﬁcation (R-M) tests and the
mini-scale (10ml) cold CaCl2-heat shock transformation
method were described previously in detail (6). In short, a
plasmid with an unmethylated recognition site will be
restricted by a restriction enzyme in the transformation
process, whereas a plasmid with no recognition site will
transform normally and produce the full number of
transformants on a selection plate such as LB agar with
ampicillin (Restriction test). A surviving plasmid from the
restriction test is recovered. This plasmid is fully modiﬁed
(methylated) and suﬀers no more restriction in the
following transformation of the restricting bacteria
(Modiﬁcation test). Plasmids used here (Table 2) are
various subclones of phage lambda (pL series) or portions
of the E. coli chromosome (pE series) cloned in either
pUC19 (12) vector or its derivative, pMECA (10), as
described previously in detail (6,9). Unmethylated plas-
mids were prepared from the strain GM272 (Dam
,
Dcm
,R

KM

K). About 10ng of DNA was used for each
transformation and ampicillin resistant colonies were
selected on L-amp agar plates.
RESULTS
Restriction Modification (R-M) testsof pTypeI
plasmid using known prototype strains
The plasmid R-M tests were applied to the newly
constructed pTypeI plasmid and 11 bacterial strains
(nine E. coli and two Salmonella–E.coli hybrid strains),
AAC------GTGC(EcoKI)                   GGA------TATC(Eco777I)                  (Eco912I) 
GAC-----RTAAY(Eco394I)            TGA--------TGCT(EcoBI)                                CACNNNNNTGGC
GTCA------TGAY(Eco851I)               CCA-------RTGC(EcoPrrI)                   TCA-------RTTCG(EcoDXXI)
GCC------TGCG(Eco585I)                  GCA------CTGA(Eco826I)                    GAA-------RTCG(Eco124II)
GAG-------ATGC(EcoEI)        GGA--------ATGC(Eco377I)                            GAA------RTCG(Eco124I)
GAG-------GTCA(EcoAI)        CCA-------CTTC(Eco646I)                  TTA-------GTCY(EcoDI) 
GATATC GATATCGAGGAGCCGCGTCATGCGACTGATTATAACCAGGATGTGCTTCATGCACCATGACTGAGTGCTGCTGGAGTTACGTATCGGTCCGAAGAATCAGTCGGTCGTTCGCACGTGGCTGGC
EcoRV                         PsiI                               SnaBI                             PmlI
GCA------GTGG(CfrAI)
GCA--------TGC(NgoAV)
CGAT-------GTTA(StySKI)                          TAA------RTCG(StySGI)
CAAA------RTCA(KpnBI)                   CGA------TACC(StySENI) 
ACA------TYCA(StySEAI)                         GAA------TGCC(KpnAI) 
AAC------GTRC(StySPI)                 GAG------RTAYG(StyLTIII) 
GATATC GATATCAACGACAGCGTACTCCAAACGATGCATCAGGTTATGCAGAGCTCGTGGTACGAAGCGAGCTGCCTACCTAAAGTACTGTCGAATTCGAGCTCGGTACCCGGGGATCCTCTAGAGATATC GATATC
EcoRV                                       SacI                 ScaI     EcoRI  SacI  KpnI    BamHI XbaI  EcoRV
MCS right MCS left
EcoRV EcoRV EcoRV
E. coli                Others
pTypeI
2900bp
A
B
A                         B
MCS right
Figure 1. pTypeI plasmid and relevant DNA sequence. A 248-bp fragment containing all 27 naturally occurring Type I sequences was cloned in the
HincII site (blunt end) of pUC19. This insert contains 17 Type I sequences (Fragment A) found in E. coli and 10 Type I sequences (Fragment B)
found in other bacteria. The 248-bp insert starts and ends at an EcoRV site. Another EcoRV site is located at the boundary of fragments A and B
such that those two fragments can be easily subcloned into other vectors. The left side (MCS left) contains half of the original MCS sequences of
pUC19: EcoRI, SacI, KpnI, SmaI, XmaI, BamHI, XbaI and ends at the remnant of HincII (GTC)–the cloning site. This MCS left portion is shown
above as a linear bar extending from the 248-bp insertion fragment, rather than as a part of the circular plasmid. A nearly identical MCS fragment
was added to the right end of the synthetic fragment (MCS right), where restriction sites are colored. Therefore, the entire group of Type I sequences
can be cut out as a cassette using any of those enzymes except for SacI. The right end of the 248-bp fragment is an EcoRV site which is connected to
the cleaved other half of the HincII site (GAC), thus the original HincII site was lost in this cloning process. In the design of the 248-bp fragment,
a few convenient unique restriction sites were added. These are PsiI, SnaBI, PmlI, and ScaI (all underlined).
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prototype enzymes. Either pUC19 or its derivative
pMECA (10) were used as negative controls. The relative
eﬃciency of transformation (EOT) values are unique to
each strain and dropped from 1.0 to 10
1 to 10
3 level
when the pTypeI plasmid was used (Table 1). This level of
restriction was observed previously with other plasmids
containing a single target recognition site (6,9). To conﬁrm
that this reduction is due to the classical restriction-
modiﬁcation phenomenon, plasmid modiﬁcation tests (6)
were also performed using the plasmids obtained from
surviving Amp
R transformants. As expected, modiﬁed
plasmids were all resistant to restriction and showed EOT
values close to 1.0 (0.9–1.7). These results show the
usefulness of pTypeI in identifying known Type I systems
in various bacterial strains.
Screeningof isoschizomers in clinical E. coli strains
To test the eﬀectiveness of pTypeI with wild-type bacteria,
we chose E. coli clinical strains obtained from Loma Linda
University Medical Center. Using the quick CaCl2 heat-
shock transformation method (6), 108 ampicillin sensitive
strains were tested for their transformation ability with the
pTypeI plasmid. The plasmid pMECA was used as a
negative control. Frequencies of transformation varied
from strain to strain and as a result, a wide range of Amp
R
colonies (from a few to 10
4) per plate were observed.
Among the 108 strains tested, 48 (44%) showed less than
20% (EOT<0.2) of the transformant numbers on pTypeI
compared to the control pMECA. This suggests that
about half of the 108 clinical strains are expressing known
Type I restriction enzyme activities.
Identification ofisoschizomers
To identify the isoschizomers, we selected 26 strains
among 48 possible Type I enzyme producers that fulﬁll
the following two criteria; (i) they produced at least 10
transformant colonies on control plates (pMECA) in our
standard plasmid restriction test; (ii) they showed clear-cut
reduction of transformant numbers (EOT<0.1) when
transformed with pTypeI.
To test those 26 candidate strains, we chose 13 plasmids
from among the plasmids we used previously (6,9,10) to
distinguish one isoschizomer producer from another.
The size of the plasmids ranged from 3kb (pL23 and
pL37) to 20kb (pL2), but most were between 5 and 9kb.
Table 2 shows the presence (+) or absence () of the
individual recognition sequence on the test plasmids.
Those test plasmids were chosen so that each prototype
will restrict a unique combination of test plasmids
showing a unique +/ pattern. Comparing this pattern
with the plasmid restriction test of the clinical E. coli
strains gives us a prediction for each isoschizomer. The 26
E. coli clinical strains described above were then subjected
to the plasmid restriction test. The +/ pattern of each
clinical strain was matched to one of the patterns in
Table 2. Thus the identities of seven diﬀerent isoschizo-
mers were predicted from 25 clinical strains (Table 2,
last column). However, the pattern of the strain EC1344
(labeled ‘
’) did not ﬁt any of the patterns in Table 2,
suggesting the presence of two or more restriction enzymes
(see below).
To conﬁrm the predicted recognition sequence
(Table 2), each clinical strain was tested with the
corresponding reference plasmid (Figure 2). Plasmid
modiﬁcation tests were also performed for further con-
ﬁrmation. A typical example of this conﬁrmation test
obtained for strain EC1446 (an EcoAI producer) is
shown in Table 3. In this example, relative eﬃciency of
transformation (EOT) values were compared to that of the
control pMECA. Non-modiﬁed (non-methylated) plas-
mids were severely restricted (center two columns—
restriction test), whereas modiﬁed (methylated) plasmids
obtained from EC1446 strain were not restricted (right
two columns—modiﬁcation test). Similar experiments
were performed for each strain and the predictions from
the Table 2 were all conﬁrmed (data not shown).
As described above, the strain EC1344 did not
ﬁt completely to any of the patterns in the Table 2. This
strain was tested using each of the 27 reference plasmids.
Interestingly, reductions of EOT values were observed
in two reference plasmids, pEco377I and pEcoKI.
Modiﬁcation tests conﬁrmed the presence of two R-M
systems (Eco377I and EcoKI) in strain EC1344,
thus Table 2 has a double entry for strain EC1344.
Since E. coli strains generally contain only one Type I
enzyme in the ﬁxed genetic location at 98.5min (so called
immigration control region), this unusual phenotype bears
further investigation.
MCS region
EcoRV EcoRV
EcoBI sequence
pEcoBI
TGANNNNNNNNTGCT
Figure 2. A diagram illustrating the design of a reference plasmid,
pEcoBI, as an example of the reference plasmid construction. In the
actual experiment, a 21mer (ATCTGAGTACGCGTTGCTGAT) that
contains a single EcoBI sequence (underlined) was cloned in the single
EcoRV site (blunt end) located in the MCS site in pMECA (13). The
ﬁnal product is an EcoBI sequence ﬂanked by EcoRV sequences. This
sequence also contains a MluI sequence (ACGCGT) in the random
sequence (NNNNNNNN) region for easy identiﬁcation of the cloned
fragment.
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among 26 E. coli strains (Table 2). Without exception, all
26 strains produce one or two Type I enzymes. The two
most common isoschizomers are Eco377I and Eco646I,
which between them account for 48% (13/27) of the R-M
systems identiﬁed in these strains. The classical Type I
enzymes (EcoBI, EcoKI and EcoAI) accounted for only
30% (8/27) in these clinical samples.
DISCUSSION
After identifying the restriction activities in bacterial cells,
it is important to know whether the restriction enzyme
in question recognizes a new prototype sequence or the
same sequence as already reported (isoschizomer). We
have developed here a new convenient tool to facilitate
this process for Type I restriction enzymes and readily
identiﬁed several isoschizomers. Isoschizomers are impor-
tant for evolutionary and population studies. For the
purpose of screening for new prototype enzymes, however,
they should be discarded swiftly.
In this survey, the simple plasmid restriction tests
revealed that nearly half of newly screened clinical E. coli
had known Type I enzymes. The remaining strains await
further investigation; they may produce either no restric-
tion enzyme, or produce new Type I or other Types
(II or III) of restriction enzymes. A previous survey of
Type II restriction enzymes in E. coli revealed Type II
isoschizomers at least in 25% (219/864) of the strains
examined (14).
The engineering of pUC19 to add unique recognition
sites for all the Type I sequences was possible simply
because each of the Type I recognition sequences reported
contain unique seven or eight nucleotides (six in the case
Table 2 Type I recognition sequences and the presence (+) or absence () of the recognition site in the test plasmid set. Assignment of the clinical
strains (EC) possessing each system
Type I enzymes Recognition sequences Plasmids in the Test Set EC strains
tested positive
pL1 pL2 pL3 pL4 pL5 pL6 pL8 pL10 pL13 pL19 pL23 pL37 pE19
E. coli system
EcoAI GAGNNNNNNNGTCA +   + 1446
EcoBI TGANNNNNNNNTGCT + + + +  +++ 1441, 1443, 1444, 1447
EcoDI TTANNNNNNNGTCY ++++ +  + 
EcoDXXI TCANNNNNNNRTTC  +  +++++ + +  ++
EcoEI GAGNNNNNNNATGC + +  +++++ +
EcoKI AACNNNNNNGTGC  + ++++ 1342, 1344
, 1394,
EcoR124I GAANNNNNNRTCG + + ++++++ + + +
EcoR124II GAANNNNNNNRTCG  +++++++  + +
EcoprrI CCANNNNNNNRTGC  + +   +  + 
Eco377I GGANNNNNNNNATGC + + ++++++ 1323, 1344
, 1386, 1427,
1430, 1456, 1476
Eco394I GACNNNNNRTAAY + + +  +   
Eco585I GCCNNNNNNTGCG  + +  + +
Eco646I CCANNNNNNNCTTC  + ++++ + 1341, 1393, 1413, 1422,
1424, 1432,
Eco777I GGANNNNNNTATC  +++++++ + + +  + 1345, 1348, 1360, 1412,
1467
Eco826I GCANNNNNNCTGA + + ++++ + 1455
Eco851I GTCANNNNNNTGAY + + +++
Eco912I CACNNNNNTGGC + +  + ++ +
Other bacterial system
StyLTIII GAGNNNNNNRTAYG + +  +  +++ +
StySEAI AGANNNNNNYTTRG ++ 
StySENI CGANNNNNNTACC  +  + + +
StySGI TAACNNNNNNNRTCG  + +   + +
StySKI CGATNNNNNNNGTTA  + +   + 
StySPI AACNNNNNNGTRC + +  ++++++
KpnAI GAANNNNNNNTGCC + +  +  ++++
KpnBI CAAANNNNNNRTCA  +++ +  + ++
CfrAI GCANNNNNNNNGTGG + + + + +  +  + +
NgoAV GCANNNNNNNNTGC + + ++++++ +  +
Table 3 Plasmid R-M tests
a of EC1446 strain
Bacteria pMECA Restriction test Modiﬁcation test
pTypeI.0 pEcoAI.0 pTypeI.1446 pEcoAI.1446
E. coli C 1.0 1.0 1.0 1.0 1.0
EC1446 1.0 7.010
3 1.410
2 0.9 1.3
Relative EOT values are shown.
Following the tradition used for modiﬁed and un-modiﬁed phages for
EOP assay, a symbol (.0) was added to the un-modiﬁed plasmids,
whereas for modiﬁed (methylated) plasmids prepared from the EC1446
strain, a symbol (.1446) was added. Amp
R transformant numbers were
normalized ﬁrst to E. coli C (non restriction enzyme producer) and then
to pMECA. Actual transformant numbers observed were between 1000
to 3000 for E. coli C and 100 to 300 for EC1446.
aFor the Restriction test, plasmids were harvested from strain GM272
(dam
, dcm
 hsdSK
) and pMECA was used as a control.
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Among the 27 Type I prototypes, however, there are four
cases (EcoKI, EcoprrI, StySPI, StySENI) where the
recognition sequences have occurred once, and one case
(StyLTIII) where it occurred three times in pUC19 and
pMECA. In the former cases, the isoschizomers (for
example, EcoKI) could be identiﬁed by comparing the
EOT values of the pUC19 and pTypeI, since a much
reduced EOT can be expected with pTypeI (two EcoKI
sites) compared to pUC19 (one EcoKI site). However,
distinguishing a plasmid with three recognition sites from
four sites is diﬃcult (6), we would have probably missed
StyLTIII isoschizomers in the present study. These Type I
sites in the vectors could be eliminated by mutations, or
the fragment can be cloned into another vector lacking
the relevant sites. Alternatively, methylated pUC19 can be
prepared in the proper host and used as a negative control.
A new speciﬁcity would be also missed if it recognized a
sequence in the plasmid backbone. This would reduce
overall transformation eﬃciency equally for test and
control plasmid. This will aﬀect a minority of possible
Type I speciﬁcities.
The Type I systems discovered in this study (total 27)
represent a small fraction of local clinical E. coli samples.
Nevertheless, we observed 7 out of the 17 known E. coli
Type I systems in these samples, including classical
EcoKI, EcoBI and EcoAI systems. Screenings for Type I
enzymes in E. coli and other enteric bacteria were
previously performed by DNA–DNA hybridization
using probes from cloned DNA for the enzymes,
EcoKI, EcoAI (15–17) and StySBLI (16,17). Since DNA
hybridization studies do not necessarily provide a DNA-
recognition sequence, it is beneﬁcial to use our present
method to obtain this critical information. Thus, it would
be extremely interesting to revisit the ECOR collection
(17) to search for Type I restriction enzymes, since it
represents E. coli samples with a wide geographical scale
and many diﬀerent origins.
The strain EC1344 seems to contain two independent
R-M systems, EcoKI and Eco377I. The mapping of the
Eco377I locus relative to the established EcoKI locus
(98.5min region) in this strain and other strains producing
only the Eco377I enzyme are crucial for the further
characterization of the strains producing Eco377I. It is
also interesting to examine the prevalence of Eco377I in
clinical samples and any possible toxin production or
connection to diseases. Recently, the Eco377I system was
also found in an E. coli strain, AO34/86, which is
eﬃciently used in the prophylaxis and treatment of
nosocomial infections and diarrhea of preterm and new-
born infants in Czech pediatric clinics (M. Weiserova,
personal communication). The Eco377I system belongs to
the same Type IB family (represented by EcoAI) as the
notoriously toxic E. coli strain, EcoAO157:H7.
It is very likely that in the near future, more Type I
prototype sequences will be identiﬁed. In such a case,
another plasmid (pTypeI#2) will be designed and used
similarly as pTypeI. In fact, a ‘super pTypeI’ plasmid
could be constructed in the future to detect an exhaustive
list of the set of Type I prototypes. If, as with Type II
enzymes, there were about 270 Type I prototypes, the
required DNA insert would still be less than 2-kb long.
Type I enzymes seem to have spread throughout the
bacterial kingdom and Archaea (3). This plasmid R-M
test, however, has an obvious limitation in that it can only
be used in the strains transformable by chemical methods
or electroporation. To expand this plasmid R-M test for
Type I enzyme screening from enteric bacteria to other
gram negative or to gram positive bacteria, the 248-bp
Type I cassette will need to be subcloned either into broad
host range vectors, or shuttle vectors able to replicate
both in E. coli and each bacterial group being tested.
An alternative would be to clone the R-M genes from a
bacterium of interest into an E. coli vector and examine
the recognition sequences in E. coli, since numerous E. coli
plasmids have already been developed for this purpose
(6,8,9). In such a case, it is possible that the expression of
the R-M genes would need to be optimized with respect to
the codon usage and other factors. Since the DNA and
protein sequences are already known, such an approach
would be particularly useful for the R-M genes already
found in various bacterial genomes.
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